In Search of the True Prevalence of COVID-19 in Africa: Time to Involve More Stakeholders

Olayinka Ilesanmi; Aanuoluwapo Afolabi

doi:10.5812/ijhls.108105

In Search of the True Prevalence of COVID-19 in Africa: Time to Involve More Stakeholders

authors:

Olayinka Ilesanmi ^{1
, *} , Aanuoluwapo Afolabi ²

1 Department of Community Medicine, University College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria

2 Department of Community Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria

International Journal of Health and Life Sciences: Vol.7, issue 4; e108105

published online: September 22, 2020

article type: Letter

received: August 1, 2020

revised: August 23, 2020

accepted: September 15, 2020

DOI: https://doi.org/10.5812/ijhls.108105

how to cite: Ilesanmi O, Afolabi A. In Search of the True Prevalence of COVID-19 in Africa: Time to Involve More Stakeholders. J Health Rep Technol. 2021;7(4):e108105. https://doi.org/10.5812/ijhls.108105.

Keywords

Prevalence Africa Coronavirus COVID-19 Community-focussed Healthcare

Footnotes

Authors' Contribution: Study concept and design: O.S., and A. A.; drafting of the manuscript: O.S., and A. A.; critical revision of the manuscript for important intellectual content: O.S., and A. A.
Conflict of Interests: We declare no conflicts of interest.
Funding/Support: No funding support.

References

1.
Kakodkar P, Kaka N, Baig MN. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). Cureus. 2020;12(4). e7560. [PubMed ID: 32269893]. [PubMed Central ID: PMC7138423]. https://doi.org/10.7759/cureus.7560.
2.
Lin CY, Cheng CH, Lu PL, Shih DC, Hung CT, Lo HH, et al. Active surveillance for suspected COVID-19 cases in inpatients with information technology. J Hosp Infect. 2020;105(2):197-9. [PubMed ID: 32243950]. [PubMed Central ID: PMC7271150]. https://doi.org/10.1016/j.jhin.2020.03.027.
3.
European Centre for Disease Control. Case definition for coronavirus disease 2019 (COVID-19). 2020, [cited July 17, 2020]. Available from: https://www.ecdc.europa.eu/en/covid-19/surveillance/case-definition.
4.
Montgomery DH. COVID-19: How it compares with other diseases in 5 charts. 2020, [cited July 17, 2020]. Available from: https://www.mprnews.org/story/2020/03/11/covid19-how-it-compares-with-other-diseases-in-5-charts.
5.
Archer SL. Archer's update on COVID-19 response from the DOM and Medicine Program. 2020, [cited June 8, 2020]. Available from: https://deptmed.queensu.ca/news/june-8-2020-dr-archers-update-covid-19-response-domand-medicine-program.
6.
Williams J. Why some people don't want to take a COVID-19 test. 2020, [cited July 17, 2020]. Available from: https://theconversation.com/why-some-people-dont-want-to-take-a-covid-19-test-141794.
7.
Carico RR, Sheppard J, Thomas CB. Community pharmacists and communication in the time of COVID-19: Applying the health belief model. Res Social Adm Pharm. 2020. [PubMed ID: 32247680]. [PubMed Central ID: PMC7118622]. https://doi.org/10.1016/j.sapharm.2020.03.017.
8.
Mendelson M, Madhi S, Nel J, Venter F. Stop random COVID-19 testing and sort the backlog. 2020, [cited July 17, 2020]. Available from: https://www.dailymaverick.co.za/article/2020-06-01-urgent-stop-random-covid-19-testing-and-sort-out-the-backlog/#gsc.tab=0.
9.
Stone J. Turnaround time longer for COVID-19 test results. 2020, [cited July 17, 2020]. Available from: https://www.smokymountainnews.com/news/item/29456-turnaround-time-longer-for-covid-19-test-results.
10.
Md Insiat Islam R. Current Drugs with Potential for Treatment of COVID-19: A Literature Review: Drugs for the Treatment Process of COVID-19. J Pharm Pharm Sci. 2020;23(1):58-64. [PubMed ID: 32251618]. https://doi.org/10.18433/jpps31002.
11.
Yao H, Chen J, Xu Y. Patients with mental health disorders in the COVID-19 epidemic. The Lancet Psychiatry. 2020;7(4). https://doi.org/10.1016/s2215-0366(20)30090-0.
12.
Wan K, Ka-ki Ho L, Wong NWM, Chiu A. Fighting COVID-19 in Hong Kong: The effects of community and social mobilization. World Development. 2020;134. https://doi.org/10.1016/j.worlddev.2020.105055.
13.
Blair RA, Morse BS, Tsai LL. Public health and public trust: Survey evidence from the Ebola Virus Disease epidemic in Liberia. Soc Sci Med. 2017;172:89-97. [PubMed ID: 27914936]. https://doi.org/10.1016/j.socscimed.2016.11.016.
14.
Onyedika-Ugoeze N. PTF calls for decentralization of COVID-19 response to LGA level, identifying high burden LGAs. 2020, [cited June 18, 2020]. Available from: https://guardian.ng/news/ptf-calls-for-decentralization-of-covid-19-resonse-to-lga-level-identifying-high-burden-lgas/..
15.
Ilesanmi O, Afolabi A. Time to Move from Vertical to Horizontal Approach in our COVID-19 Response in Nigeria. SciMedicine Journal. 2020;2:28-9. https://doi.org/10.28991/SciMedJ-2020-02-SI-3.
16.
Barrett R, Brown PJ. Stigma in the time of influenza: social and institutional responses to pandemic emergencies. J Infect Dis. 2008;197 Suppl 1:S34-S7. [PubMed ID: 18269326]. https://doi.org/10.1086/524986.
17.
Centers for Disease Control and Prevention. Coronavirus Disease 2019: Reducing Stigma. 2020, [cited July 18, 2020]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/reducing-stigma.html.
18.
Ilesanmi OS, Akande A, Afolabi AA. Overcoming COVID-19 in West African countries: is herd immunity an option? The Pan African Medical Journal. 2020;35(103).

comments